Global Therapeutic Stent Market Size By Type (Metallic Biomaterials, Polymeric Biomaterials), By Application (Hospitals And Cardiac Centers, Ambulatory Surgical Centers), By Region, And Segment Foreca...

The Global Therapeutic Stent Market was valued at USD 10.6 billion in 2023 and is projected to reach USD 17.9 billion by 2031, growing at a CAGR of 6.6% during the forecast period from 2023 to 2031. The growth is primarily driven by the increasing prevalence of cardiovascular diseases, advancements in minimally invasive surgical techniques, and the rising adoption of bioresorbable and drug-eluting stents. Therapeutic stents play a pivotal role in restoring blood flow and preventing artery blockage, significantly improving patient outcomes in cases of coronary and peripheral artery disease.

Drivers:

1. Rising Cardiovascular Disease Burden:

An increasing global incidence of coronary artery disease and peripheral vascular disorders is a major driver. Therapeutic stents are critical in interventional cardiology procedures, where timely restoration of blood flow is essential.

2. Technological Advancements:

The market is witnessing innovation in stent design, material, and drug-coating technologies. The development of next-generation bioresorbable stents and nanotechnology-based stents enhances treatment efficacy and safety.

3. Growing Geriatric Population:

With age being a key risk factor for cardiovascular conditions, the expanding elderly population significantly contributes to the demand for therapeutic stents globally.

Restraints:

1. High Cost of Advanced Stents:

Premium pricing associated with drug-eluting and bioresorbable stents, along with complex reimbursement scenarios in emerging economies, may limit broader adoption.

2. Risk of Restenosis and Complications:

Despite improvements, issues such as in-stent restenosis, late thrombosis, and post-procedural complications remain concerns that restrain market growth.

Opportunity:

1. Emerging Markets & Healthcare Expansion:

Rapid healthcare infrastructure development in Asia-Pacific, Latin America, and parts of Africa presents untapped growth opportunities. Increasing health awareness and access to insurance are boosting procedural volumes.

2. Rise in Outpatient and Minimally Invasive Procedures:

A global trend toward same-day angioplasty and minimally invasive procedures is accelerating demand for compact and efficient therapeutic stents that reduce hospital stay and recovery time.

Market by System Type Insights:

Based on system type, the Drug-Eluting Stents (DES) segment held the largest market share in 2023. DES offer reduced restenosis rates and superior outcomes compared to bare-metal stents. The Bioresorbable Stents segment is expected to grow at the highest CAGR due to growing physician preference for temporary scaffolding solutions that reduce long-term complications.

Market by End-use Insights:

Hospitals dominated the end-use segment in 2023, accounting for more than 50% of global revenue. This dominance is attributed to advanced infrastructure and a high volume of cardiovascular procedures. Ambulatory Surgical Centers (ASCs) are expected to witness rapid growth, driven by cost-effectiveness and increasing demand for outpatient interventions.

Market by Regional Insights:

North America led the global therapeutic stent market in 2023 due to a high prevalence of cardiovascular diseases, strong healthcare infrastructure, and favorable reimbursement policies. Asia-Pacific is poised for the fastest growth, supported by rising healthcare investments, aging demographics, and a surge in lifestyle-related illnesses in countries like China and India.

Competitive Scenario:

Key players in the global therapeutic stent market include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Terumo Corporation, Cook Medical, MicroPort Scientific Corporation, Lepu Medical Technology, and Sahajanand Medical Technologies. These companies focus on product innovation, clinical trials, and geographic expansion to strengthen market share.

Key Market Developments:

2023: Abbott received FDA approval for a next-gen bioresorbable stent with enhanced visibility and drug delivery.

2024: Boston Scientific launched a new drug-coated peripheral stent tailored for diabetic patients.

2025: Medtronic collaborated with hospitals across Asia to pilot AI-assisted stent placement solutions.

Scope of Work – Global Therapeutic Stent Market

FAQs:

1. What is the current market size of the Global Therapeutic Stent Market?

The market was valued at USD 10.6 billion in 2023.

2. What is the major growth driver of the Global Therapeutic Stent Market?

The major driver is the increasing prevalence of cardiovascular diseases and the growing demand for minimally invasive treatments.

3. Which is the largest region during the forecast period in the Global Therapeutic Stent Market?

North America is the largest region due to its advanced healthcare infrastructure and high adoption rates.

4. Which segment accounted for the largest market share in the Global Therapeutic Stent Market?

The Drug-Eluting Stents (DES) segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Therapeutic Stent Market?

Key players include Abbott Laboratories, Boston Scientific, Medtronic, BIOTRONIK, and Terumo Corporation.